![]() There are a wide variety of IPCDs available, but it is uncertain if they vary in effectiveness. Thromboprophylaxis regimens include pharmacological and mechanical options such as intermittent pneumatic compression devices (IPCDs). ![]() Anatomic success of the procedure and duration of symptoms were independent predictors of DVT recurrence. Venous thromboembolism (VTE), which encompasses deep vein thrombosis (DVT) and pulmonary embolism (PE), is a serious potential complication in hospitalized patients. However, recurrence occurred more frequently in patients with subacute DVT than in those with acute DVT. The anatomic success (HR, 52.3 95% CI, 3.82–715.21 p = 0.003) and symptom duration (HR, 17.58 95% CI, 1.89–163.34 p = 0.012) were predictive factors associated with recurrence.Ĭonclusions: Single-session PMT is safe and effective for immediate symptom relief in acute and subacute DVT patients. Deep vein thrombosis and its causes: Treatment. The recurrence-free survival rate in the acute DVT group was significantly ( p = 0.015) better than that in the subacute DVT group. A central venous catheter, a tube placed in the vein during medical treatment. Clinical outcomes were not different between the two groups. The anatomic success rate was 97% and the clinical success rate was 95%. Results: A large-bore aspiration thrombectomy was used in 80 (80%) cases, Angiojet (Boston Scientific, Marlborough, MA, USA) device in one (1%) case, and a combination of both techniques in 19 (19%) cases. Drugs: Anticoagulant medicines can help thin the blood, inhibiting the formation of blood clots in the leg and other parts of the body. PE is responsible for almost all VTE related deaths. VTE is a major public health concern, estimated to effect 1 to 2 per 1,000 people in the US each year (1-3). These patients were divided into an acute DVT group (< 14 days, n = 75) and a subacute DVT group (15–28 days, n = 25). Venous thromboembolism (VTE) is a spectrum of disease including deep vein thrombosis (DVT) and pulmonary embolism (PE). Materials and Methods: From January 2018 to March 2021, 100 consecutive patients (age: 64.64 ± 17.28 years male, 42%) with symptomatic DVT who underwent single-session PMT were enrolled for this study. ![]() Objectives: To evaluate the efficacy and safety of single-session percutaneous mechanical thrombectomy (PMT) for deep vein thrombosis (DVT), to compare clinical outcomes and recurrences between acute and subacute DVT, and to identify factors predicting recurrence.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |